Additional file 1. List of all 92 proteins with their significance in trends among patient subgroups. List of the 92 ProseekŽ Oncology I v2 proteins in order of significance showing a trend of log values when comparing serum samples of healthy women versus benign ovarian disease versus early stage serous ovarian cancer versus late stage serous ovarian cancer. The log data for the top 12 proteins are graphed in Fig. 4
Additional file 2: Table S2. Glycosite-containing peptides identified from glycoproteomic analysis f...
Among the gynaecological malignancies, ovarian cancer is one of the neoplastic forms with the poores...
Masses (m/z) and intensities of the peaks with the highest values of the univariate statistical test...
Additional file 4. AUC and sensitivity for all 92 proteins comparing early stage ovarian cancer vers...
Additional file 2: Table 2. CA125 values in the clinical analyses and the PEA NPX values for some o...
Additional file 1: Table 1. P-values of individual proteins in the discovery step
Additional file 2: Table S2 Average Chi Square value per gene symbol for ovarian cancer versus norma...
Ovarian cancer is the fifth leading cause of cancer death in women in the U.S. Currently, two serum ...
Abstract Background Currently, there are no FDA approved screening tools for detecting early stage o...
Additional file 2: Figure S1âS3. Comparisons of the fluctuation patterns of blood glucose, serum i...
Additional file 2: Figure S1. Density equalizing map of global ovarian cancer incidence numbers. Map...
We set out to discover ovarian cancer biomarkers useful for monitoring progression during and after ...
One reason that ovarian cancer is such a deadly disease is because it is not usually diagnosed until...
Purpose: To evaluate the utility of an enhanced biomarker discovery approach in order to identify po...
Table S1. Prognostic molecular markers in published studies. Table S2. The relationship between mole...
Additional file 2: Table S2. Glycosite-containing peptides identified from glycoproteomic analysis f...
Among the gynaecological malignancies, ovarian cancer is one of the neoplastic forms with the poores...
Masses (m/z) and intensities of the peaks with the highest values of the univariate statistical test...
Additional file 4. AUC and sensitivity for all 92 proteins comparing early stage ovarian cancer vers...
Additional file 2: Table 2. CA125 values in the clinical analyses and the PEA NPX values for some o...
Additional file 1: Table 1. P-values of individual proteins in the discovery step
Additional file 2: Table S2 Average Chi Square value per gene symbol for ovarian cancer versus norma...
Ovarian cancer is the fifth leading cause of cancer death in women in the U.S. Currently, two serum ...
Abstract Background Currently, there are no FDA approved screening tools for detecting early stage o...
Additional file 2: Figure S1âS3. Comparisons of the fluctuation patterns of blood glucose, serum i...
Additional file 2: Figure S1. Density equalizing map of global ovarian cancer incidence numbers. Map...
We set out to discover ovarian cancer biomarkers useful for monitoring progression during and after ...
One reason that ovarian cancer is such a deadly disease is because it is not usually diagnosed until...
Purpose: To evaluate the utility of an enhanced biomarker discovery approach in order to identify po...
Table S1. Prognostic molecular markers in published studies. Table S2. The relationship between mole...
Additional file 2: Table S2. Glycosite-containing peptides identified from glycoproteomic analysis f...
Among the gynaecological malignancies, ovarian cancer is one of the neoplastic forms with the poores...
Masses (m/z) and intensities of the peaks with the highest values of the univariate statistical test...